Search filters

List of works by Takeru Shiroiwa

Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery.

scientific article published on 17 June 2011

Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery: The N-SAS BC 02 Trial ⬇️

scientific article published on June 2, 2011

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.

scientific article

Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance Claims.

scientific article

Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer

scientific article published on 26 July 2015

Cost-effectiveness analysis of KRAS testing and cetuximab as last-line therapy for colorectal cancer.

scientific article published in December 2010

Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.

scientific article published in January 2009

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

scientific article

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial.

scientific article published on 29 September 2011

Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan

scientific article published on 18 May 2020

Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial.

scientific article published on 15 December 2011

Development of Japanese utility weights for the Adult Social Care Outcomes Toolkit (ASCOT) SCT4

scientific article published on 04 September 2019

Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan.

scientific article published on 21 October 2016

EQ-5D-Y Population Norms for Japanese Children and Adolescents

scientific article published in 2021

Exploring the Application of Cost-Effectiveness Evaluation in the Japanese National Health Insurance System

scientific article published on 21 March 2019

Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System

scientific article published on 16 December 2019

Health utility scores of colorectal cancer based on societal preference in Japan.

scientific article

Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records.

scientific article

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.

scientific article published on 17 October 2017

Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life 2 years after breast cancer surgery ⬇️

scientific article published on August 30, 2012

Institutional care versus home care for the elderly in a rural area: cost comparison in rural Japan

scientific article published on 13 September 2012

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

scientific article published on 01 April 2010

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.

scientific article published on 25 August 2015

Japanese translation and cross-cultural validation of the Adult Social Care Outcomes Toolkit (ASCOT) in Japanese social service users

scientific article published on 11 April 2019

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial

scientific article published on 12 August 2016

New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations

scientific article

Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan.

scientific article published on 4 March 2010

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer.

scientific article

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity

scientific article published on 26 June 2019

QALY and productivity loss: empirical evidence for "double counting"

scientific article published on 15 May 2013

Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making

scientific article published on 01 June 2016

The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan.

scientific article

The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data.

scientific article

To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?

scientific article published on 03 November 2018

WTP for a QALY and health states: More money for severer health states?

scientific article published on September 2013

Paulina is supported by:

About Paulina

Help